Xueliang Wang
Appearances
- DateMay 20, 2024BACKGROUND: Around 80-85% of colorectal cancer (CRC) belongs to ‘immune cold’ microsatellite stable (MSS) subtype without responsive to anti-PD-1 mAb therapy…
Presenter
Speakers
The Chinese University of Hong Kong